Core Molding Technologies, Inc. (NYSEAMERICAN:CMT) CEO Sells $225,209.42 in Stock

Core Molding Technologies, Inc. (NYSEAMERICAN:CMT) CEO David L. Duvall sold 13,919 shares of Core Molding Technologies stock in a transaction dated Friday, December 20th. The stock was sold at an average price of $16.18, for a total value of $225,209.42. Following the completion of the transaction, the chief executive officer now owns 257,512 shares in the company, valued at $4,166,544.16. The trade was a 5.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Core Molding Technologies Stock Up 0.9 %

CMT opened at $16.59 on Thursday. The company has a current ratio of 2.41, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $148.65 million, a price-to-earnings ratio of 9.37 and a beta of 1.75. Core Molding Technologies, Inc. has a 12-month low of $14.64 and a 12-month high of $21.00.

Core Molding Technologies (NYSEAMERICAN:CMT) last announced its quarterly earnings data on Tuesday, November 5th. The industrial products company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.13. The business had revenue of $72.99 million for the quarter, compared to the consensus estimate of $71.57 million. Core Molding Technologies had a net margin of 4.95% and a return on equity of 10.76%. On average, sell-side analysts anticipate that Core Molding Technologies, Inc. will post 1.64 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Core Molding Technologies during the 2nd quarter worth approximately $27,000. LSV Asset Management bought a new stake in Core Molding Technologies in the 2nd quarter valued at $36,000. MetLife Investment Management LLC increased its holdings in Core Molding Technologies by 131.0% in the 3rd quarter. MetLife Investment Management LLC now owns 4,460 shares of the industrial products company’s stock valued at $77,000 after buying an additional 2,529 shares during the period. Barclays PLC raised its stake in shares of Core Molding Technologies by 278.9% in the 3rd quarter. Barclays PLC now owns 9,942 shares of the industrial products company’s stock valued at $172,000 after buying an additional 7,318 shares in the last quarter. Finally, Rhumbline Advisers lifted its holdings in shares of Core Molding Technologies by 8.4% during the 2nd quarter. Rhumbline Advisers now owns 11,174 shares of the industrial products company’s stock worth $178,000 after acquiring an additional 866 shares during the period. Institutional investors own 58.79% of the company’s stock.

About Core Molding Technologies

Core Molding Technologies, Inc, together with its subsidiaries, operates as a molder of thermoplastic and thermoset structural products. The company offers a range of manufacturing processes that include compression molding of sheet molding compound, resin transfer molding, liquid molding of dicyclopentadiene, spray-up and hand-lay-up, direct long-fiber thermoplastics, and structural foam and structural web injection molding.